Source:http://linkedlifedata.com/resource/pubmed/id/21402922
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
14
|
pubmed:dateCreated |
2011-4-6
|
pubmed:abstractText |
Hepatitis C is a common infection with significant morbidity and mortality, and only a minority of patients successfully clear the infection. Identification of factors that influence disease progression in HCV infection is difficult owing to the lack of well-defined patient cohorts. However, recent evidence supports a role for the innate immune system in virus clearance. In this study, we investigated innate immune genes for their contribution to disease progression in a unique cohort of well-controlled HCV-infected patients. The Irish cohort of HCV patients is uniquely homogenous; patients were infected with a single genotype of HCV from contaminated anti-D Ig. We genotyped 543 infected patients, including 247 patients who spontaneously resolved infection, for natural killer (NK) cell-associated killer cell Ig-like receptors (KIR) genes and the recently reported IL28B (IFN?3) SNP. The NK cell gene KIR2DS3 was significantly increased in patients with chronic infection [odds ratio (OR) 1.90, 95% confidence interval (CI) 1.25-2.90, P < 0.002]. The IL28B "T" allele was also significantly increased in chronically infected patients (OR 7.38, 95% CI 4.93-11.07, P < 10(-8)). The presence of both markers synergized to significantly increase the risk of chronic infection over either factor alone (OR 20.11, 95% CI 9.05-44.68, P < 10(-7)). In functional experiments, we found that IL28A significantly inhibited IFN-? production by NK cells. Thus, we demonstrate a functional link between NK cells and type 3 IFN. Our findings may contribute to the development of a prognostic test for HCV and identify therapeutic strategies for the clinical management of HCV-infected patients.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1091-6490
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
5
|
pubmed:volume |
108
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5736-41
|
pubmed:dateRevised |
2011-10-5
|
pubmed:meshHeading |
pubmed-meshheading:21402922-Genotype,
pubmed-meshheading:21402922-Hepacivirus,
pubmed-meshheading:21402922-Hepatitis C,
pubmed-meshheading:21402922-Humans,
pubmed-meshheading:21402922-Immunity, Innate,
pubmed-meshheading:21402922-Interleukins,
pubmed-meshheading:21402922-Ireland,
pubmed-meshheading:21402922-Killer Cells, Natural,
pubmed-meshheading:21402922-Odds Ratio,
pubmed-meshheading:21402922-Polymorphism, Single Nucleotide,
pubmed-meshheading:21402922-Receptors, KIR,
pubmed-meshheading:21402922-Risk Factors
|
pubmed:year |
2011
|
pubmed:articleTitle |
Innate immune genes synergize to predict increased risk of chronic disease in hepatitis C virus infection.
|
pubmed:affiliation |
Natural Killer Cell Group, School of Biochemistry and Immunology, Trinity College, Dublin 2, Ireland.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|